HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 11, November 2019 – Evaluating cost effectiveness of genomic profiling       » Ion treatment offers new hope for cancer patients       » Empowering sustainability through innovation       » Meeting clinical needs in Asia with HealthTech       » The key in diagnosis and treatment       » Singapore's first private co-working laboratory and office space       » Singapore-based MedTech company announced as winner of 2019 Asia Pacific Showcase Competition at The MedTech Forum      
EDITOR'S LETTER
Rare diseases are more common than you think. Some of these are genetic-related such as haemophilia, Pompe disease, and muscular dystrophy, to name a few. Early intervention is important for rare disease patients but sadly, many affected are still facing the difficulty of getting accurate diagnosis timely. Yet, only 5% of 7,000 rare diseases have treatment approved by FDA.

Shire is one of the companies in Asia Pacific that provides therapies for patients with rare and threatening diseases, supporting campaigns to improve diagnosis on rare diseases and developing disease awareness and diagnosis programmes with patient organizations. The company has a state-of-the-art manufacturing site for its haematological pipelines in Singapore. On the other hand, ASEAN+ Rare Disease Network has been set up by several rare disease patient groups in ASEAN countries and Hong Kong. You can learn more about these stories in the Features section.

In Spotlights, this issue features Professor Jackie Y. Ying, the Executive Director at Institute of Bioengineering and Nanotechnology (IBN) in Singapore; and Dr Tran Thanh Huong, who shared with us some efforts on cancer control and care carried out in Vietnam. APBN also exclusively interviewed three of the young TR Innovators under 35, gaining more understanding on their bright ideas and innovations.

We hope you learn something new and have a great time reading our magazine.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at jwloh@wspc.com

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 
Click here for the complete issue.

NEWS CRUNCH  
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy